Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
Year: 2003
Type: article
Source: PubMed
Authors: Ilka B Schiffer, Susanne Gebhard, Carolin K Heimerdinger, Annette Heling, Jochem Hast, Ursula Wollscheid, Barbara Seliger, Berno Tanner, Sandra Gilbert, Thomas Beckers, Silke Baasner, Walburgis Brenner, Christian Spangenberg, Dirk Prawitt, Tatjana Trost, Wolfgang G Schreiber, Bernhard Zabel, Manfred Thelen, Hans-Anton Lehr, Franz Oesch, Jan G Hengstler
Institution: Johannes Gutenberg University Mainz
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1574405077
